HomeEQL • STO
add
EQL Pharma AB
Previous close
kr 79.92
Day range
kr 79.00 - kr 79.90
Year range
kr 38.40 - kr 90.60
Market cap
2.30B SEK
Avg Volume
15.95K
P/E ratio
66.65
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 92.22M | 31.35% |
Operating expense | 22.90M | -3.56% |
Net income | 10.06M | 54.62% |
Net profit margin | 10.91 | 17.69% |
Earnings per share | — | — |
EBITDA | 16.39M | 45.52% |
Effective tax rate | 20.62% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.56M | 49.39% |
Total assets | 460.80M | 35.68% |
Total liabilities | 252.85M | 51.78% |
Total equity | 207.96M | — |
Shares outstanding | 29.06M | — |
Price to book | 11.16 | — |
Return on assets | 8.39% | — |
Return on capital | 10.44% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 10.06M | 54.62% |
Cash from operations | 7.62M | 207.71% |
Cash from investing | -12.68M | 71.65% |
Cash from financing | 8.79M | -72.38% |
Net change in cash | 3.73M | 135.73% |
Free cash flow | -12.71M | 73.33% |
About
Founded
2006
Website
Employees
28
